| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.075 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.029 | 0.6 |